Novartis Agrees to Buy Avidity Biosciences in $12 Billion Deal

Bloomberg Tech 3 days ago 90

Novartis AG agreed to buy biotechnology company Avidity Biosciences Inc. in a deal that values it at $12 billion, according to the Swiss drugmaker.

BankBit shares this Content always with

Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)

CC License

Read Entire Article

Screenshot generated in real time with SneakPeek Suite

BANKBIT | FINANCIAL WORLD NEWS

The latest Top News, from leading exponents of , Stock Market, BlockChain, New Economy Accredited Sources.

Since 2015, our Mission was to Share, up-to-date, those News and Information we believe to represent in an Ethical and sincere manner the current Financial and Banking World.

| Learn More |

Financial Market Knowledge Base

Cryptocurrency Knowledge Base

BANKB.IT | Latest Financial NEWS

Please support BANKBIT: if you like it, share your favorite News to your Socials!